Anning He
Impact in
- Toxicology top 10%
- Bioactive Compounds and Antitumor Agents
-
- Cancer-related Molecular Pathways
- Pancreatic and Hepatic Oncology Research
Papers in
-
- CRISPR and Genetic Engineering 4
- RNA Interference and Gene Delivery 2
- Viral Infectious Diseases and Gene Expression in Insects 2
- Oncology 5
- Cancer-related Molecular Pathways 3
- Co-authors
- Monica Hollstein (2 shared papers)W P Bennett (2 shared papers)David P. Lane (1 shared paper)Robert A. Metcalf (1 shared paper)Ilja Küsters (1 shared paper)James H. Resau (1 shared paper)Judith A. Welsh (1 shared paper)B F Trump (1 shared paper)
- Journals
- Oncology Reports (2 papers)Toxicology and Industrial Health (1 paper)Cancer Letters (1 paper)Anti-Cancer Drugs (1 paper)Drug Design Development and Therapy (1 paper)
- Partner nations
- ChinaUnited StatesSweden
In The Last Decade
Anning He
13 papers receiving 377 citations
Peers
Comparison fields: 5 of 58
- Toxicology 32
- Oncology 204
- Biotechnology 43
- Otorhinolaryngology 20
- Cancer Research 53
Countries citing papers authored by Anning He
This map shows the geographic impact of Anning He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anning He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anning He more than expected).
Fields of papers citing papers by Anning He
This network shows the impact of papers produced by Anning He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anning He. The network helps show where Anning He may publish in the future.
Co-authors
The 25 scholars most cited alongside Anning He, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | p53 mutation and protein accumulation during multistage human esophageal carcinogenesis. | 1992 | 185 |
| 2 | Circulating anti-p53 antibodies in esophageal cancer patients are found predominantly in individuals with p53 core domain mutations in their tumors. | 1996 | 64 |
| 3 | 2015 | 53 | |
| 4 | 2018 | 30 | |
| 5 | 2012 | 15 | |
| 6 | 2013 | 11 | |
| 7 | 2010 | 10 | |
| 8 | 2012 | 6 | |
| 9 | 2015 | 4 | |
| 10 | 2012 | 2 | |
| 11 | 2014 | 2 | |
| 12 | 2015 | 2 | |
| 13 | Retrovirus-mediated Drosophila melanogaster multisubstrate deoxyribonucleoside kinase gene therapy of gastric cancer cells in vitro and in vivo. | 2010 | 2 |
About Anning He
Anning He is a scholar working on Molecular Biology, Oncology, Genetics, Pharmacology and Toxicology, having authored 13 papers that have together received 386 indexed citations. Recurring topics across this work include Virus-based gene therapy research (5 papers), CRISPR and Genetic Engineering (4 papers), Cancer-related Molecular Pathways (3 papers), Cancer Genomics and Diagnostics (2 papers), RNA Interference and Gene Delivery (2 papers), Bioactive Compounds and Antitumor Agents (2 papers), Viral Infectious Diseases and Gene Expression in Insects (2 papers) and Phytochemistry and biological activity of medicinal plants (2 papers). The work is most often cited by research in Toxicology (32 citations), Oncology (204 citations), Biotechnology (43 citations), Otorhinolaryngology (20 citations) and Cancer Research (53 citations). Anning He has collaborated with scholars based in China, United States and Sweden. Frequent co-authors include Monica Hollstein, W P Bennett, David P. Lane, Robert A. Metcalf, Ilja Küsters, James H. Resau, Judith A. Welsh, B F Trump, Shoutian Zhu and Xinyu Zheng. Their work appears in journals such as Oncology Reports, Toxicology and Industrial Health, Cancer Letters, Anti-Cancer Drugs and Drug Design Development and Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.